{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:17:35Z","timestamp":1792171055643,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Swedish Heart and Lung foundation","award":["20130271"],"award-info":[{"award-number":["20130271"]}]},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Calcitonin gene-related peptide (CGRP) is part of the calcitonin peptide family, which includes calcitonin (CT), amylin (AMY), and adrenomedullin (ADM). CGRP and its receptor are highly present in the trigeminovascular system (TVS). Recent research suggests that other members of the calcitonin family could be feasible therapeutic targets in the treatment of migraine. The present study aims to elucidate the distribution of ADM, AMY, CT, and their receptors in the rat TVS, and to explore potential sex differences in their expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Trigeminal ganglia (TG) were dissected from male and female adult rats. Protein and gene expression were assessed through immunohistochemistry and RT-qPCR. Additionally, the dura mater was isolated for further investigation of protein expression and fiber localization using immunohistochemistry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Quantitative gene expression analysis revealed the presence of all genes in male and female TGs, except for calcitonin receptor (CTR). Notably, CGRP mRNA levels in TG were several folds higher than those of other genes. The receptor activity-modifying protein-1 (RAMP1) mRNA levels were significantly higher in female compared to male.<\/jats:p>\n                    <jats:p>No AMY or CT immunoreactivity was observed in the TVS. In contrast, immunoreactivity for ADM, CGRP, RAMP1, CTR, and calcitonin-like receptor (CLR) were observed in the cytoplasm of TG neurons. Immunoreactive A\u03b4-fibers storing RAMP1, ADM and CLR were also identified. RAMP2 and RAMP3 were expressed in nucleus of TG neurons and in satellite glial cells. Furthermore, RAMP1 and CLR were co-localized with CASPR in the nodes of Ranvier located in A\u03b4-fibers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides valuable insights into the distribution of the CGRP family of peptides and their receptors in the TVS. CGRP mRNA levels in the TG were markedly higher than those of other genes, demonstrating the key role of CGRP. The co-localization of CLR and RAMP1 on A\u03b4-fibers with CASPR suggests a potential role for this receptor in modulating trigeminal nerve function and neuronal excitability, with implications for migraine pathophysiology. Additionally, RAMP1 mRNA levels were significantly higher in female TG compared to males, indicating sex-specific differences in gene expression. These findings underscore the need for further research into the functional significance of gender-related variations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10194-024-01893-1","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T03:54:06Z","timestamp":1731038046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Sex differences in expression of CGRP family of receptors and ligands in the rat trigeminal system"],"prefix":"10.1186","volume":"25","author":[{"given":"Aida","family":"Maddahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob C. A.","family":"Edvinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Edvinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"issue":"2","key":"1893_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41582-022-00763-1","volume":"19","author":"TJ Steiner","year":"2023","unstructured":"Steiner TJ, Stovner LJ (2023) Global epidemiology of migraine and its implications for public health and health policy. Nat Reviews Neurol 19(2):109\u2013117","journal-title":"Nat Reviews Neurol"},{"issue":"10258","key":"1893_CR2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"C Abbafati","year":"2020","unstructured":"Abbafati C, Machado D, Cislaghi B, Salman O, Karanikolos M, McKee M et al (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of Disease Study 2019. Lancet 396(10258):1204\u20131222","journal-title":"Lancet"},{"key":"1893_CR3","doi-asserted-by":"crossref","unstructured":"Steiner T, Stovner L, Jensen R, Uluduz D, Katsarava Z, Headache LTBGC (2020) Migraine remains second among the world\u2019s causes of disability, and first among young women: findings from GBD2019. Springer, pp 1\u20134","DOI":"10.1186\/s10194-020-01208-0"},{"issue":"5","key":"1893_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68(5):343\u2013349","journal-title":"Neurology"},{"issue":"11","key":"1893_CR5","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","volume":"17","author":"LJ Stovner","year":"2018","unstructured":"Stovner LJ, Nichols E, Steiner TJ, Abd-Allah F, Abdelalim A, Al-Raddadi RM et al (2018) Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol 17(11):954\u2013976","journal-title":"Lancet Neurol"},{"issue":"4","key":"1893_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S1474-4422(20)30482-8","volume":"20","author":"KG Vetvik","year":"2021","unstructured":"Vetvik KG, MacGregor EA (2021) Menstrual migraine: a distinct disorder needing greater recognition. Lancet Neurol 20(4):304\u2013315","journal-title":"Lancet Neurol"},{"key":"1893_CR7","doi-asserted-by":"publisher","first-page":"523475","DOI":"10.3389\/fnins.2020.00222","volume":"14","author":"P Gazerani","year":"2020","unstructured":"Gazerani P, Cairns BE (2020) Sex-specific pharmacotherapy for migraine: a narrative review. Front NeuroSci 14:523475","journal-title":"Front NeuroSci"},{"issue":"10","key":"1893_CR8","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41582-021-00544-2","volume":"17","author":"DN Krause","year":"2021","unstructured":"Krause DN, Warfvinge K, Haanes KA, Edvinsson L (2021) Hormonal influences in migraine\u2014interactions of oestrogen, oxytocin and CGRP. Nat Reviews Neurol 17(10):621\u2013633","journal-title":"Nat Reviews Neurol"},{"issue":"3","key":"1893_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1177\/0333102417728873","volume":"39","author":"K Warfvinge","year":"2019","unstructured":"Warfvinge K, Edvinsson L (2019) Distribution of CGRP and CGRP receptor components in the rat brain. Cephalalgia 39(3):342\u2013353","journal-title":"Cephalalgia"},{"issue":"4","key":"1893_CR10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/j.pain.0000000000000831","volume":"158","author":"S Iyengar","year":"2017","unstructured":"Iyengar S, Ossipov MH, Johnson KW (2017) The role of calcitonin gene\u2013related peptide in peripheral and central pain mechanisms including migraine. Pain 158(4):543\u2013559","journal-title":"Pain"},{"issue":"4","key":"1893_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1177\/1073858405275554","volume":"11","author":"D Pietrobon","year":"2005","unstructured":"Pietrobon D (2005) Migraine: new molecular mechanisms. Neuroscientist 11(4):373\u2013386","journal-title":"Neuroscientist"},{"issue":"2","key":"1893_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.neuroscience.2010.05.016","volume":"169","author":"S Eftekhari","year":"2010","unstructured":"Eftekhari S, Salvatore CA, Calamari A, Kane SA, Tajti J, Edvinsson L (2010) Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion. Neuroscience 169(2):683\u2013696","journal-title":"Neuroscience"},{"issue":"5961","key":"1893_CR13","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/308746a0","volume":"308","author":"HR Morris","year":"1984","unstructured":"Morris HR, Panico M, Etienne T, Tippins J, Girgis SI, MacIntyre I (1984) Isolation and characterization of human calcitonin gene-related peptide. Nature 308(5961):746\u2013748","journal-title":"Nature"},{"issue":"2","key":"1893_CR14","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1152\/physrev.00059.2021","volume":"103","author":"AF Russo","year":"2023","unstructured":"Russo AF, Hay DL (2023) CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond. Physiol Rev 103(2):1565\u20131644","journal-title":"Physiol Rev"},{"issue":"3","key":"1893_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/bph.15605","volume":"179","author":"TA Rees","year":"2022","unstructured":"Rees TA, Hendrikse ER, Hay DL, Walker CS (2022) Beyond CGRP: the calcitonin peptide family as targets for migraine and pain. Br J Pharmacol 179(3):381\u2013399","journal-title":"Br J Pharmacol"},{"key":"1893_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1146\/annurev-pharmtox-010814-124701","volume":"55","author":"AF Russo","year":"2015","unstructured":"Russo AF (2015) Calcitonin gene-related peptide (CGRP): a new target for migraine. Annu Rev Pharmacol Toxicol 55:533\u2013552","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"1893_CR17","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","volume":"94","author":"FA Russell","year":"2014","unstructured":"Russell FA, King R, Smillie S-J, Kodji X, Brain S (2014) Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev 94(4):1099\u20131142","journal-title":"Physiol Rev"},{"issue":"9","key":"1893_CR18","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/head.14388","volume":"62","author":"ML Garelja","year":"2022","unstructured":"Garelja ML, Hay DL (2022) A narrative review of the calcitonin peptide family and associated receptors as migraine targets: calcitonin gene-related peptide and beyond. Headache: J Head Face Pain 62(9):1093\u20131104","journal-title":"Headache: J Head Face Pain"},{"issue":"20","key":"1893_CR19","doi-asserted-by":"publisher","first-page":"e2488","DOI":"10.1212\/WNL.0000000000011930","volume":"96","author":"H Ghanizada","year":"2021","unstructured":"Ghanizada H, Al-Mahdi Al-Karagholi M, Arngrim N, M\u00f8rch-Rasmussen M, Walker CS, Hay DL et al (2021) Effect of adrenomedullin on migraine-like attacks in patients with migraine: a randomized crossover study. Neurology 96(20):e2488\u2013e99","journal-title":"Neurology"},{"issue":"2","key":"1893_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1124\/pr.54.2.233","volume":"54","author":"DR Poyner","year":"2002","unstructured":"Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W et al (2002) International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54(2):233\u2013246","journal-title":"Pharmacol Rev"},{"issue":"1","key":"1893_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bph.14075","volume":"175","author":"DL Hay","year":"2018","unstructured":"Hay DL, Garelja ML, Poyner DR, Walker CS (2018) Update on the pharmacology of calcitonin\/CGRP family of peptides: IUPHAR Review 25. Br J Pharmacol 175(1):3\u201317","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1893_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/0333102418765787","volume":"39","author":"ER Hendrikse","year":"2019","unstructured":"Hendrikse ER, Bower RL, Hay DL, Walker CS (2019) Molecular studies of CGRP and the CGRP family of peptides in the central nervous system. Cephalalgia 39(3):403\u2013419","journal-title":"Cephalalgia"},{"issue":"1","key":"1893_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S1474-4422(16)30293-9","volume":"16","author":"KG Vetvik","year":"2017","unstructured":"Vetvik KG, MacGregor EA (2017) Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol 16(1):76\u201387","journal-title":"Lancet Neurol"},{"issue":"1","key":"1893_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-022-01524-7","volume":"23","author":"A Maddahi","year":"2022","unstructured":"Maddahi A, Edvinsson L, Warfvinge K (2022) Expression of vasopressin and its receptors in migraine-related regions in CNS and the trigeminal system: influence of sex. J Headache Pain 23(1):1\u201320","journal-title":"J Headache Pain"},{"issue":"1","key":"1893_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-020-01197-0","volume":"21","author":"K Warfvinge","year":"2020","unstructured":"Warfvinge K, Krause DN, Maddahi A, Edvinsson JC, Edvinsson L, Haanes KA (2020) Estrogen receptors \u03b1, \u03b2 and GPER in the CNS and trigeminal system-molecular and functional aspects. J Headache Pain 21(1):1\u201316","journal-title":"J Headache Pain"},{"issue":"S1","key":"1893_CR26","first-page":"1","volume":"34","author":"DN Krause","year":"2020","unstructured":"Krause DN, Warfvinge K, Grell A-S, Edvinsson J, Haanes KA, Edvinsson L (2020) Oxytocin as a regulatory neuropeptide in the trigeminovascular system: localization, expression and function of oxytocin and oxytocin receptors. FASEB J 34(S1):1","journal-title":"FASEB J"},{"issue":"12","key":"1893_CR27","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1177\/0333102420929027","volume":"40","author":"K Warfvinge","year":"2020","unstructured":"Warfvinge K, Krause DN, Maddahi A, Grell A-S, Edvinsson JC, Haanes KA et al (2020) Oxytocin as a regulatory neuropeptide in the trigeminovascular system: localization, expression and function of oxytocin and oxytocin receptors. Cephalalgia 40(12):1283\u20131295","journal-title":"Cephalalgia"},{"issue":"1","key":"1893_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-023-01687-x","volume":"24","author":"A Maddahi","year":"2023","unstructured":"Maddahi A, Warfvinge K, Holm A, Edvinsson JC, Reducha PV, Kazantzi S et al (2023) Progesterone distribution in the trigeminal system and its role to modulate sensory neurotransmission: influence of sex. J Headache Pain 24(1):1\u201316","journal-title":"J Headache Pain"},{"key":"1893_CR29","first-page":"2","volume":"11","author":"SJ Wimalawansa","year":"1997","unstructured":"Wimalawansa SJ (1997) Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit Reviews\u2122 Neurobiol 11:2\u20133","journal-title":"Crit Reviews\u2122 Neurobiol"},{"key":"1893_CR30","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s12031-020-01493-z","volume":"70","author":"L Edvinsson","year":"2020","unstructured":"Edvinsson L, Grell A-S, Warfvinge K (2020) Expression of the CGRP family of neuropeptides and their receptors in the trigeminal ganglion. J Mol Neurosci 70:930\u2013944","journal-title":"J Mol Neurosci"},{"key":"1893_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-019-1055-3","volume":"20","author":"JC Edvinsson","year":"2019","unstructured":"Edvinsson JC, Warfvinge K, Krause DN, Blixt FW, Sheykhzade M, Edvinsson L et al (2019) C-fibers may modulate adjacent A\u03b4-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system. J Headache Pain 20:1\u201310","journal-title":"J Headache Pain"},{"issue":"5","key":"1893_CR32","first-page":"1188","volume":"52","author":"J Hansen-Schwartz","year":"2003","unstructured":"Hansen-Schwartz J, Hoel NL, Zhou M, Xu CB, Svendgaard NA, Edvinsson L (2003) Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery 52(5):1188\u20131194 (94\u2009\u2013\u20095)","journal-title":"Neurosurgery"},{"issue":"1","key":"1893_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s10194-024-01744-z","volume":"25","author":"TA Rees","year":"2024","unstructured":"Rees TA, Tasma Z, Garelja ML, O\u2019Carroll SJ, Walker CS, Hay DL (2024) Calcitonin receptor, calcitonin gene-related peptide and amylin distribution in C1\/2 dorsal root ganglia. J Headache Pain 25(1):36","journal-title":"J Headache Pain"},{"issue":"5","key":"1893_CR34","doi-asserted-by":"publisher","first-page":"R697","DOI":"10.1152\/ajpregu.00338.2020","volume":"320","author":"TA Rees","year":"2021","unstructured":"Rees TA, Hay DL, Walker CS (2021) Amylin antibodies frequently display cross-reactivity with CGRP: characterization of eight amylin antibodies. Am J Physiology-Regulatory Integr Comp Physiol 320(5):R697\u2013R703","journal-title":"Am J Physiology-Regulatory Integr Comp Physiol"},{"key":"1893_CR35","first-page":"331","volume-title":"Discovery of CGRP in relation to migraine","author":"L Edvinsson","year":"2019","unstructured":"Edvinsson L, Goadsby PJ (2019) Discovery of CGRP in relation to migraine. SAGE Publications Sage UK, London, England, pp 331\u2013332"},{"issue":"8","key":"1893_CR36","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1468-2982.2003.00719.x","volume":"24","author":"L Edvinsson","year":"2004","unstructured":"Edvinsson L (2004) Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache. Cephalalgia 24(8):611\u2013622","journal-title":"Cephalalgia"},{"issue":"6","key":"1893_CR37","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","volume":"14","author":"L Edvinsson","year":"2018","unstructured":"Edvinsson L, Haanes KA, Warfvinge K, Krause DN (2018) CGRP as the target of new migraine therapies\u2014successful translation from bench to clinic. Nat Reviews Neurol 14(6):338\u2013350","journal-title":"Nat Reviews Neurol"},{"issue":"2","key":"1893_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/bcp.12618","volume":"80","author":"L Edvinsson","year":"2015","unstructured":"Edvinsson L (2015) CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment. Br J Clin Pharmacol 80(2):193\u2013199","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"1893_CR39","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S1474-4422(21)00409-9","volume":"21","author":"L Al-Hassany","year":"2022","unstructured":"Al-Hassany L, Goadsby PJ, Danser AJ, MaassenVanDenBrink A (2022) Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions. Lancet Neurol 21(3):284\u2013294","journal-title":"Lancet Neurol"},{"key":"1893_CR40","unstructured":"Rees TA, Amylin (2021) CGRP and the AMY1 receptor: localisation in the trigeminal ganglia and receptor regulation. ResearchSpace@ Auckland"},{"issue":"S2","key":"1893_CR41","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1002\/(SICI)1096-9136(199706)14:2+<S9::AID-DIA397>3.0.CO;2-D","volume":"14","author":"B Ludvik","year":"1997","unstructured":"Ludvik B, Kautzky-Willer A, Prager R, Thomaseth K, Pacini G (1997) Amylin: history and overview. Diabet Med 14(S2):S9\u2013S13","journal-title":"Diabet Med"},{"key":"1893_CR42","doi-asserted-by":"crossref","unstructured":"Wysolmerski JJ (2018) Parathyroid hormone, parathyroid hormone\u2013related protein, and calcitonin. Elsevier, Vitamin D, pp 849\u2013870","DOI":"10.1016\/B978-0-12-809965-0.00046-X"},{"issue":"9","key":"1893_CR43","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJMoa2314577","volume":"391","author":"M Ashina","year":"2024","unstructured":"Ashina M, Phul R, Khodaie M, L\u00f6f E, Florea I (2024) A monoclonal antibody to PACAP for migraine prevention. N Engl J Med 391(9):800\u2013809","journal-title":"N Engl J Med"},{"issue":"3","key":"1893_CR44","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1006\/bbrc.1994.1827","volume":"201","author":"S Sugo","year":"1994","unstructured":"Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J et al (1994) Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 201(3):1160\u20131166","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"1893_CR45","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/jcbfm.1987.126","volume":"7","author":"L Edvinsson","year":"1987","unstructured":"Edvinsson L, Ekman R, Jansen I, McCulloch J, Uddman R (1987) Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects. J Cereb Blood Flow Metabolism 7(6):720\u2013728","journal-title":"J Cereb Blood Flow Metabolism"},{"issue":"8","key":"1893_CR46","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/sj.bjp.0704210","volume":"133","author":"P Hasbak","year":"2001","unstructured":"Hasbak P, Sams A, Schifter S, Longmore J, Edvinsson L (2001) CGRP receptors mediating CGRP-, adrenomedullin\u2010and amylin\u2010induced relaxation in porcine coronary arteries. Characterization with \u2018Compound 1\u2019(WO98\/11128), a non\u2010peptide antagonist. Br J Pharmacol 133(8):1405\u20131413","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1893_CR47","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/0333102417739584","volume":"39","author":"A Labastida-Ram\u00edrez","year":"2019","unstructured":"Labastida-Ram\u00edrez A, Rubio-Beltr\u00e1n E, Villal\u00f3n CM, MaassenVanDenBrink A (2019) Gender aspects of CGRP in migraine. Cephalalgia 39(3):435\u2013444","journal-title":"Cephalalgia"},{"issue":"9","key":"1893_CR48","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/jamaneurol.2023.2335","volume":"80","author":"F Porreca","year":"2023","unstructured":"Porreca F, Dodick DW (2023) Considering patient sex in prescribing CGRP receptor antagonists for short-term treatment of migraine. JAMA Neurol 80(9):885\u2013886","journal-title":"JAMA Neurol"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01893-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-024-01893-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01893-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T05:02:29Z","timestamp":1731042149000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-024-01893-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1893"],"URL":"https:\/\/doi.org\/10.1186\/s10194-024-01893-1","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]},"assertion":[{"value":"4 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal of the study followed the guidelines of the European Communities Council (86\/609\/ECC) and was approved by the Regional Ethical Committee on Animal Research, Malm\u00f6\/Lund, Sweden (M17-15). All animal experiments were therefore performed in accordance with the European Community Council Directive on \u2018The Protection of Animals Used for Scientific Purposes\u2019 (2010\/63\/EU).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and understood the study and approve on its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"193"}}